140 related articles for article (PubMed ID: 34936301)
21. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.
Murayama T; Nakaoku T; Enari M; Nishimura T; Tominaga K; Nakata A; Tojo A; Sugano S; Kohno T; Gotoh N
Cancer Res; 2016 Feb; 76(4):974-83. PubMed ID: 26837769
[TBL] [Abstract][Full Text] [Related]
24. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
25. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.
Laskin J; Liu SV; Tolba K; Heining C; Schlenk RF; Cheema P; Cadranel J; Jones MR; Drilon A; Cseh A; Gyorffy S; Solca F; Duruisseaux M
Ann Oncol; 2020 Dec; 31(12):1693-1703. PubMed ID: 32916265
[TBL] [Abstract][Full Text] [Related]
26. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
[TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery.
Tang XP; Li J; Yu LC; Chen YC; Shi SB; Zhu LR; Chen P
Lung Cancer; 2013 Aug; 81(2):273-9. PubMed ID: 23756092
[TBL] [Abstract][Full Text] [Related]
29. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
Wang H; Wang J; Liang CF; Zhou T
Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
[TBL] [Abstract][Full Text] [Related]
30. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC).
Sui JYAX
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283
[TBL] [Abstract][Full Text] [Related]
31. MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway.
Jiang Z; Zhang J; Chen F; Sun Y
Thorac Cancer; 2020 Feb; 11(2):415-425. PubMed ID: 31883226
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
Wang T; Li W; Li W; Liu L; Zhang H
J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
[TBL] [Abstract][Full Text] [Related]
33. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.
Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D
Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441
[TBL] [Abstract][Full Text] [Related]
35. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
36. NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Trombetta D; Rossi A; Fabrizio FP; Sparaneo A; Graziano P; Fazio VM; Muscarella LA
Curr Med Chem; 2017; 24(38):4213-4228. PubMed ID: 28901268
[TBL] [Abstract][Full Text] [Related]
37. Role of EIF4G1 network in non-small cell lung cancers (NSCLC) cell survival and disease progression.
Del Valle L; Dai L; Lin HY; Lin Z; Chen J; Post SR; Qin Z
J Cell Mol Med; 2021 Mar; 25(6):2795-2805. PubMed ID: 33539648
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
39. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy.
Naumnik W; Nilklińska W; Ossolińska M; Chyczewska E
Folia Histochem Cytobiol; 2009; 47(4):703-9. PubMed ID: 20430742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
